Welcome to our dedicated page for DOCGO news (Ticker: DCGO), a resource for investors and traders seeking the latest updates and insights on DOCGO stock.
DocGo Inc. (NASDAQ: DCGO) is a provider of technology-enabled mobile health and medical transportation services, and its news flow reflects this focus on out‑of‑facility care. Company press releases highlight developments in its mobile health services, remote patient monitoring, ambulance and medical transport operations, and its 50‑state virtual care network.
Investors following DocGo news can expect regular updates on financial results, including quarterly earnings announcements furnished on Form 8‑K, where the company discusses segment performance for Mobile Health Services and Transportation Services, adjusted gross margin metrics and adjusted EBITDA. These releases often include commentary from management on contract activity, care gap closure volumes, and the evolution of its payer and provider relationships.
DocGo’s news also covers contract wins and program launches, such as care gap closure programs with insurance providers, population health initiatives with public health plans and tribal and state health departments, vaccination programs with counties, and multi‑year ambulance contracts with academic medical systems and municipalities. Announcements describing longitudinal care services and transitions of care programs illustrate how the company uses mobile clinicians and telehealth to engage patients at home.
Another recurring theme in DocGo news is strategic activity and capital allocation. The company has issued releases and filed 8‑Ks regarding the acquisition of virtual care platform SteadyMD, as well as updates on its share repurchase program. In addition, DocGo frequently announces participation in healthcare and growth investor conferences, providing insight into how management presents its strategy to the market.
For anyone tracking DCGO, this news page aggregates these earnings releases, contract announcements, program launches, acquisition updates and conference appearances in one place, offering a consolidated view of the company’s operational and strategic milestones over time.
DocGo (NASDAQ: DCGO), a prominent provider of last-mile mobile health services, announced its participation in four investor conferences in November. These include the Citi Consumer Disruptive Growth Conference on November 14, the Needham Virtual Health Tech 1x1 Conference on November 16, the Canaccord Genuity Medtech, Diagnostics and Digital Health Forum on November 17, and the BTIG Digital Health Forum on November 21. The company aims to showcase its innovative mobile health solutions that bridge the gap between physical and virtual healthcare.
DocGo (Nasdaq: DCGO) reported Q3 2022 revenue of $104.3 million, a 22% increase year-over-year. Net income surged 213% to $2.5 million. Adjusted EBITDA rose 110% to $8.4 million. The company revised its full-year revenue guidance to $430-$440 million, up from $425-$435 million, citing organic growth and M&A activities. CEO Stan Vashovsky will retire on December 31, with President Anthony Capone succeeding him. The mobile health revenue increased by 12.9% while transportation services revenue surged 55%.
DocGo (NASDAQ: DCGO) has secured a $90 million secured line of credit (LOC) from Citibank, N.A. The LOC, which includes a $50 million accordion option, has a five-year term. CFO Andre Oberholzer indicates that the funds will support opportunistic M&A and working capital as the company seeks to expand its mobile health services. DocGo aims to leverage its strong balance sheet and positive cash flow for growth opportunities in new territories, enhancing its position in last-mile mobile healthcare.
DocGo, a leader in mobile health services, has launched a new application in the App Blossom Gallery, enhancing integration with Epic EHR systems. This application allows users to request and track on-demand medical services, improving efficiency and accuracy by integrating with electronic medical records. It replaces a previous integration and is available to hospitals contracted with DocGo. According to Hawk Newton, CTO of DocGo, this development represents a significant advance in healthcare technology, ultimately improving patient access to care.
DocGo (NASDAQ: DCGO) is set to announce its third-quarter results for the period ending September 30, 2022, on November 7, 2022, after the market closes. A conference call for analysts and investors will follow at 5:00 PM ET on the same day. DocGo specializes in last-mile mobile health services, aiming to provide affordable and high-quality care directly to patients, enhancing telehealth capabilities through innovative technology. For further details, visit their investor relations website.
DocGo (NASDAQ: DCGO) expands its On-Demand urgent care services, now covering most of New York City, Westchester, and Nassau Counties, along with parts of New Jersey. This service allows users to book same-day house calls and telehealth consultations, offering high-quality, affordable healthcare directly to patients. A notable 20% of patients were repeat customers in September, highlighting the service's popularity. The launch of the DocGo On-Demand iOS app facilitates easy access to urgent care, signaling a shift in how healthcare is delivered.
DocGo (NASDAQ: DCGO), a mobile health services provider, announced its participation in LD Micro's The Main Event investor conference on October 25 at 11:00 AM ET. The event will feature Vice President of Investor Relations, Michael Cole, who will discuss the company's innovative approach to healthcare delivery. DocGo aims to enhance patient care through last-mile mobile services and telehealth solutions, bridging the gap between physical and virtual care. The presentation will be available via webcast on DocGo's investor relations website.
DocGo (NASDAQ: DCGO) is enhancing its partnership with Gary and Mary West PACE by launching a remote patient monitoring (RPM) program aimed at improving care for PACE participants. This innovative approach combines RPM with telehealth consultations and urgent care services, enabling proactive in-home care that reduces hospital visits and overall healthcare costs. The pilot program, running through 2022, aims to monitor patients more effectively and improve chronic disease outcomes. DocGo emphasizes its capability to provide real-time interventions via its advanced mobile health solutions, which are designed to integrate seamlessly into existing healthcare systems.
DocGo (NASDAQ: DCGO) announced that its mobile health services are now available to Cigna commercial customers in New York and New Jersey, effective October 1, 2022. This agreement aims to enhance accessibility to healthcare by providing timely and cost-effective treatments outside traditional facilities. DocGo offers various at-home services, including wellness exams, vaccines, and diagnostic tests, ensuring a patient-centric approach. The company strives to bridge gaps in healthcare access, promoting personalized and convenient care.
DocGo, a prominent mobile health services provider (NASDAQ: DCGO), has expanded its services in the UK through its subsidiary, Ambulnz Community Partners. The company announced the acquisition of three new contracts that will enhance its operations in Greater Manchester, Lancashire, and Merseyside, focusing on urgent and planned care ambulance transportation.
These contracts are set for a minimum duration of three years and aim to improve patient flow in local hospitals. The expansion reflects DocGo's commitment to accessible healthcare for UK communities.